Proteosome influenza vaccine
US6743900B2 · kind B2 · utility
9Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2001 |
| Grant date | Jun 1, 2004 |
| Priority date | — |
| Expiry date | Feb 15, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.